retatrutide launch Eli Lilly's weight loss drug isn't FDA approved, but one patient got access through a “compassionate use” pathway. What is compassionate use and what is this experimental drug? We've got answers When Will Retatrutide Be FDA

Phase 2 trials have also highlighted other possible side effects, like injection site reactions

"Weve leveraged our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today," Hims & Hers co-founder and CEO Andrew Dudum said in a statement announcing the new drugs

Understanding your genetic predispositions ($99 add-on after your first month) helps your provider predict whether you're likely to respond optimally at standard or higher doses, enabling smarter dose planning from the beginning of treatment

PlexusDx Precision Peptide Genetic Test can reveal predispositions in GLP1R, GIPR, FTO, and MC4R pathways to support provider conversations

Unlike earlier GLP-1 receptor agonists such as semaglutide, retatrutide is what scientists call a "triple agonist" because it simultaneously activates three different hormone receptors in your body

Lifestyle Matters: Combining the medication with a healthy diet and exercise leads to the best results